Novo Nordisk is slashing prices again for its popular obesity treatment Wegovy.
But doctors insist the expense is still a big challenge for patients without insurance.
Novo Nordisk is slashing prices again for its popular obesity treatment Wegovy.
But doctors insist the expense is still a big challenge for patients without insurance.